Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis, Ulcerative | 163 | 2025 | 1926 | 28.660 |
Why?
|
Inflammatory Bowel Diseases | 156 | 2025 | 2442 | 23.510 |
Why?
|
Crohn Disease | 144 | 2025 | 2294 | 21.170 |
Why?
|
Gastrointestinal Agents | 29 | 2024 | 510 | 6.310 |
Why?
|
Biological Therapy | 10 | 2022 | 140 | 5.030 |
Why?
|
Tumor Necrosis Factor-alpha | 30 | 2023 | 4356 | 3.900 |
Why?
|
Clostridium Infections | 16 | 2020 | 562 | 3.340 |
Why?
|
Hospitalization | 47 | 2024 | 10847 | 3.130 |
Why?
|
Colectomy | 15 | 2022 | 699 | 2.770 |
Why?
|
Immunologic Factors | 18 | 2023 | 1597 | 2.530 |
Why?
|
Remission Induction | 21 | 2024 | 2408 | 2.150 |
Why?
|
Immunosuppressive Agents | 17 | 2023 | 4207 | 2.070 |
Why?
|
Feces | 21 | 2024 | 1510 | 2.020 |
Why?
|
Biological Products | 8 | 2022 | 947 | 1.980 |
Why?
|
Fatigue | 5 | 2025 | 1557 | 1.930 |
Why?
|
Colonoscopy | 15 | 2023 | 1410 | 1.900 |
Why?
|
Gastroenterology | 11 | 2024 | 593 | 1.900 |
Why?
|
Severity of Illness Index | 34 | 2024 | 15951 | 1.820 |
Why?
|
Enterocolitis, Pseudomembranous | 7 | 2017 | 264 | 1.770 |
Why?
|
Vitamin D | 13 | 2016 | 3311 | 1.760 |
Why?
|
Humans | 391 | 2025 | 768970 | 1.730 |
Why?
|
Vitamin D Deficiency | 12 | 2018 | 1388 | 1.720 |
Why?
|
Environment | 5 | 2018 | 1122 | 1.710 |
Why?
|
Leukocyte L1 Antigen Complex | 7 | 2023 | 93 | 1.600 |
Why?
|
Adult | 189 | 2024 | 223851 | 1.510 |
Why?
|
Colorectal Neoplasms | 16 | 2021 | 6982 | 1.420 |
Why?
|
Risk Factors | 105 | 2024 | 74976 | 1.410 |
Why?
|
Anti-Inflammatory Agents | 12 | 2021 | 1811 | 1.330 |
Why?
|
Female | 214 | 2024 | 397515 | 1.280 |
Why?
|
Colitis, Microscopic | 5 | 2022 | 71 | 1.260 |
Why?
|
Middle Aged | 150 | 2024 | 223737 | 1.230 |
Why?
|
Multivariate Analysis | 31 | 2021 | 12095 | 1.230 |
Why?
|
Male | 181 | 2024 | 365203 | 1.190 |
Why?
|
Proctocolectomy, Restorative | 4 | 2024 | 191 | 1.160 |
Why?
|
Gastrointestinal Hemorrhage | 8 | 2020 | 1126 | 1.130 |
Why?
|
Immunoglobulin Fab Fragments | 4 | 2015 | 446 | 1.120 |
Why?
|
Prospective Studies | 64 | 2024 | 54962 | 1.090 |
Why?
|
Smoking | 17 | 2024 | 9094 | 1.090 |
Why?
|
Incidence | 41 | 2024 | 21547 | 1.060 |
Why?
|
Young Adult | 71 | 2024 | 60131 | 1.060 |
Why?
|
Phenotype | 26 | 2024 | 16731 | 1.050 |
Why?
|
Constipation | 5 | 2018 | 570 | 1.050 |
Why?
|
Cholangitis, Sclerosing | 4 | 2024 | 179 | 1.040 |
Why?
|
Retrospective Studies | 76 | 2024 | 81903 | 1.010 |
Why?
|
Pouchitis | 2 | 2024 | 64 | 1.000 |
Why?
|
Electronic Health Records | 18 | 2020 | 4879 | 0.980 |
Why?
|
Environmental Exposure | 6 | 2024 | 4544 | 0.960 |
Why?
|
Anus Diseases | 2 | 2014 | 54 | 0.930 |
Why?
|
Antirheumatic Agents | 3 | 2022 | 1381 | 0.930 |
Why?
|
Aged | 99 | 2024 | 171786 | 0.890 |
Why?
|
Cohort Studies | 44 | 2024 | 41808 | 0.890 |
Why?
|
Colonic Pouches | 2 | 2022 | 122 | 0.880 |
Why?
|
Dietary Fiber | 4 | 2018 | 767 | 0.870 |
Why?
|
Colon | 9 | 2023 | 1803 | 0.870 |
Why?
|
Sarcopenia | 2 | 2018 | 377 | 0.860 |
Why?
|
Colitis | 3 | 2021 | 1242 | 0.860 |
Why?
|
Polyethylene Glycols | 4 | 2015 | 1197 | 0.840 |
Why?
|
Recurrence | 16 | 2023 | 8513 | 0.840 |
Why?
|
Steroids | 2 | 2019 | 938 | 0.830 |
Why?
|
Antibodies, Monoclonal | 12 | 2019 | 9264 | 0.820 |
Why?
|
Odds Ratio | 19 | 2022 | 9684 | 0.810 |
Why?
|
Curcumin | 1 | 2023 | 97 | 0.810 |
Why?
|
Drug Monitoring | 5 | 2021 | 965 | 0.800 |
Why?
|
Quality of Life | 21 | 2024 | 13510 | 0.790 |
Why?
|
Follow-Up Studies | 40 | 2023 | 39394 | 0.790 |
Why?
|
Delivery, Obstetric | 3 | 2020 | 955 | 0.780 |
Why?
|
Alopecia Areata | 1 | 2024 | 130 | 0.770 |
Why?
|
Gastrointestinal Tract | 4 | 2021 | 840 | 0.770 |
Why?
|
Mucous Membrane | 2 | 2017 | 659 | 0.760 |
Why?
|
Pyoderma Gangrenosum | 2 | 2022 | 84 | 0.760 |
Why?
|
Inpatients | 7 | 2021 | 2569 | 0.760 |
Why?
|
Case-Control Studies | 31 | 2024 | 22296 | 0.750 |
Why?
|
Risk Assessment | 27 | 2021 | 24333 | 0.750 |
Why?
|
Wound Healing | 3 | 2019 | 2815 | 0.750 |
Why?
|
Logistic Models | 23 | 2024 | 13318 | 0.750 |
Why?
|
Breast Feeding | 4 | 2018 | 1364 | 0.740 |
Why?
|
Polypharmacy | 1 | 2024 | 307 | 0.740 |
Why?
|
Age Factors | 23 | 2024 | 18435 | 0.740 |
Why?
|
Venous Thromboembolism | 4 | 2022 | 1881 | 0.740 |
Why?
|
Treatment Outcome | 43 | 2024 | 65480 | 0.720 |
Why?
|
Gastrointestinal Transit | 3 | 2017 | 101 | 0.720 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2017 | 888 | 0.720 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2025 | 878 | 0.710 |
Why?
|
Neoplasms | 12 | 2024 | 22389 | 0.700 |
Why?
|
Diet Surveys | 3 | 2020 | 1160 | 0.690 |
Why?
|
Opportunistic Infections | 2 | 2020 | 375 | 0.690 |
Why?
|
Pregnancy Complications | 5 | 2021 | 2974 | 0.680 |
Why?
|
C-Reactive Protein | 8 | 2023 | 3859 | 0.670 |
Why?
|
Adolescent | 55 | 2024 | 89244 | 0.670 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2019 | 2276 | 0.660 |
Why?
|
Hospital Mortality | 9 | 2015 | 5369 | 0.660 |
Why?
|
Length of Stay | 12 | 2017 | 6526 | 0.660 |
Why?
|
Disease Progression | 15 | 2023 | 13674 | 0.660 |
Why?
|
Metagenomics | 2 | 2020 | 474 | 0.660 |
Why?
|
United States | 54 | 2024 | 73186 | 0.650 |
Why?
|
Second-Look Surgery | 1 | 2019 | 27 | 0.650 |
Why?
|
Psoriasis | 2 | 2019 | 926 | 0.650 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2025 | 10400 | 0.630 |
Why?
|
Liver Transplantation | 5 | 2020 | 2403 | 0.630 |
Why?
|
Diet | 11 | 2024 | 8088 | 0.580 |
Why?
|
Puerperal Disorders | 1 | 2020 | 304 | 0.580 |
Why?
|
Eosinophilic Esophagitis | 1 | 2021 | 205 | 0.580 |
Why?
|
Dietary Fats | 2 | 2017 | 2002 | 0.580 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2017 | 46 | 0.580 |
Why?
|
Comorbidity | 16 | 2022 | 10592 | 0.580 |
Why?
|
Metabolomics | 3 | 2023 | 1675 | 0.580 |
Why?
|
Health Care Costs | 4 | 2023 | 3270 | 0.570 |
Why?
|
Adrenal Cortex Hormones | 7 | 2024 | 1892 | 0.570 |
Why?
|
International Classification of Diseases | 6 | 2020 | 936 | 0.570 |
Why?
|
Anal Canal | 3 | 2019 | 376 | 0.560 |
Why?
|
Hospitals, Special | 1 | 2017 | 90 | 0.550 |
Why?
|
Patient Care Management | 1 | 2020 | 304 | 0.550 |
Why?
|
Registries | 12 | 2019 | 8384 | 0.550 |
Why?
|
After-Hours Care | 1 | 2017 | 102 | 0.550 |
Why?
|
Anti-Bacterial Agents | 11 | 2024 | 7478 | 0.540 |
Why?
|
Chronic Disease | 12 | 2022 | 9384 | 0.540 |
Why?
|
Absenteeism | 1 | 2018 | 247 | 0.540 |
Why?
|
Ambulatory Care | 3 | 2015 | 2784 | 0.540 |
Why?
|
Proportional Hazards Models | 19 | 2024 | 12562 | 0.540 |
Why?
|
Health Services Research | 3 | 2016 | 1818 | 0.540 |
Why?
|
Gastrointestinal Diseases | 2 | 2018 | 1204 | 0.530 |
Why?
|
Malnutrition | 3 | 2021 | 632 | 0.530 |
Why?
|
Hygiene | 1 | 2016 | 95 | 0.530 |
Why?
|
Drug Tolerance | 1 | 2018 | 365 | 0.520 |
Why?
|
Sanitation | 1 | 2016 | 83 | 0.520 |
Why?
|
Aged, 80 and over | 29 | 2021 | 59739 | 0.510 |
Why?
|
Colonic Neoplasms | 3 | 2021 | 2543 | 0.510 |
Why?
|
Prognosis | 25 | 2020 | 30046 | 0.490 |
Why?
|
Genotype | 14 | 2024 | 13048 | 0.490 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 789 | 0.490 |
Why?
|
Time Factors | 25 | 2021 | 40261 | 0.490 |
Why?
|
Genetic Research | 2 | 2015 | 173 | 0.490 |
Why?
|
Methotrexate | 2 | 2019 | 1723 | 0.480 |
Why?
|
Tobacco Smoke Pollution | 2 | 2018 | 828 | 0.480 |
Why?
|
Hepatitis B, Chronic | 2 | 2016 | 413 | 0.480 |
Why?
|
Decision Support Techniques | 4 | 2014 | 2008 | 0.480 |
Why?
|
Ostomy | 1 | 2014 | 33 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.470 |
Why?
|
Immunocompromised Host | 1 | 2020 | 863 | 0.470 |
Why?
|
Immune System Diseases | 1 | 2017 | 253 | 0.460 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2014 | 87 | 0.460 |
Why?
|
Fatty Acids | 2 | 2023 | 1812 | 0.460 |
Why?
|
Bacteriological Techniques | 1 | 2015 | 277 | 0.450 |
Why?
|
Natural Language Processing | 7 | 2019 | 1203 | 0.450 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2014 | 86 | 0.440 |
Why?
|
Hepatitis C | 3 | 2015 | 1595 | 0.440 |
Why?
|
Cyclosporine | 1 | 2016 | 777 | 0.440 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2023 | 16053 | 0.440 |
Why?
|
Ileostomy | 1 | 2014 | 122 | 0.440 |
Why?
|
Azathioprine | 3 | 2013 | 354 | 0.430 |
Why?
|
Celiac Disease | 3 | 2021 | 820 | 0.430 |
Why?
|
Genetic Predisposition to Disease | 17 | 2024 | 18068 | 0.430 |
Why?
|
Checklist | 1 | 2020 | 841 | 0.430 |
Why?
|
Algorithms | 15 | 2024 | 14201 | 0.430 |
Why?
|
Computer Security | 1 | 2015 | 260 | 0.420 |
Why?
|
Perineum | 1 | 2014 | 212 | 0.420 |
Why?
|
Workload | 2 | 2009 | 852 | 0.420 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2015 | 162 | 0.420 |
Why?
|
Blood Sedimentation | 1 | 2014 | 236 | 0.420 |
Why?
|
Weight Gain | 2 | 2020 | 2359 | 0.420 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.410 |
Why?
|
Intestinal Mucosa | 3 | 2023 | 3044 | 0.410 |
Why?
|
Proteomics | 3 | 2021 | 3914 | 0.410 |
Why?
|
Chemoprevention | 2 | 2014 | 326 | 0.410 |
Why?
|
Medical Informatics | 3 | 2015 | 742 | 0.400 |
Why?
|
Drug Therapy, Combination | 9 | 2024 | 6320 | 0.400 |
Why?
|
Endoscopy | 4 | 2022 | 1862 | 0.400 |
Why?
|
Physicians | 3 | 2020 | 4607 | 0.400 |
Why?
|
Salvage Therapy | 1 | 2019 | 1277 | 0.400 |
Why?
|
Physician's Role | 1 | 2019 | 926 | 0.400 |
Why?
|
Cecal Neoplasms | 1 | 2011 | 27 | 0.380 |
Why?
|
Emergency Service, Hospital | 5 | 2020 | 7957 | 0.380 |
Why?
|
Colonic Polyps | 2 | 2019 | 557 | 0.380 |
Why?
|
Meat | 1 | 2014 | 588 | 0.380 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.380 |
Why?
|
Zinc | 1 | 2015 | 677 | 0.380 |
Why?
|
Abdominal Abscess | 1 | 2013 | 153 | 0.380 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2749 | 0.380 |
Why?
|
Cost-Benefit Analysis | 5 | 2016 | 5544 | 0.370 |
Why?
|
Cross Infection | 3 | 2017 | 1425 | 0.370 |
Why?
|
Sleep | 3 | 2016 | 4820 | 0.370 |
Why?
|
Hospitals | 7 | 2022 | 3904 | 0.370 |
Why?
|
Confidentiality | 1 | 2015 | 606 | 0.360 |
Why?
|
Enteral Nutrition | 6 | 2023 | 802 | 0.360 |
Why?
|
Life Style | 4 | 2022 | 3931 | 0.350 |
Why?
|
Health Status Indicators | 1 | 2016 | 971 | 0.350 |
Why?
|
Parturition | 1 | 2014 | 456 | 0.350 |
Why?
|
Piperidines | 4 | 2024 | 1667 | 0.350 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.350 |
Why?
|
Ecology | 1 | 2010 | 105 | 0.340 |
Why?
|
Depressive Disorder | 2 | 2013 | 3723 | 0.340 |
Why?
|
Population Surveillance | 3 | 2015 | 2597 | 0.340 |
Why?
|
DNA Methylation | 1 | 2024 | 4432 | 0.340 |
Why?
|
North America | 3 | 2020 | 1290 | 0.340 |
Why?
|
Esophageal and Gastric Varices | 2 | 2009 | 215 | 0.330 |
Why?
|
Prevalence | 16 | 2024 | 15879 | 0.330 |
Why?
|
Depression | 5 | 2022 | 8231 | 0.330 |
Why?
|
Hepatitis B | 1 | 2015 | 711 | 0.330 |
Why?
|
Risk | 9 | 2024 | 9621 | 0.330 |
Why?
|
Boston | 6 | 2018 | 9377 | 0.320 |
Why?
|
Affect | 1 | 2016 | 1500 | 0.310 |
Why?
|
Anticoagulants | 3 | 2015 | 4850 | 0.310 |
Why?
|
Glucocorticoids | 1 | 2018 | 2167 | 0.310 |
Why?
|
Cesarean Section | 2 | 2014 | 1426 | 0.310 |
Why?
|
Feeding Behavior | 2 | 2020 | 3205 | 0.310 |
Why?
|
Diabetes Mellitus | 4 | 2015 | 5892 | 0.310 |
Why?
|
Ruminococcus | 2 | 2018 | 11 | 0.310 |
Why?
|
Intra-Abdominal Fat | 3 | 2018 | 625 | 0.310 |
Why?
|
Early Detection of Cancer | 4 | 2019 | 3238 | 0.310 |
Why?
|
Withholding Treatment | 1 | 2013 | 620 | 0.310 |
Why?
|
Contraceptives, Oral | 3 | 2018 | 561 | 0.310 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2748 | 0.300 |
Why?
|
Arthritis, Rheumatoid | 4 | 2019 | 3780 | 0.300 |
Why?
|
Wrist Injuries | 1 | 2010 | 215 | 0.300 |
Why?
|
Biological Factors | 2 | 2021 | 156 | 0.300 |
Why?
|
Hyperplasia | 2 | 2021 | 1154 | 0.300 |
Why?
|
Cross-Sectional Studies | 17 | 2024 | 26395 | 0.300 |
Why?
|
Metagenome | 3 | 2024 | 465 | 0.290 |
Why?
|
Thrombosis | 1 | 2022 | 2956 | 0.290 |
Why?
|
Caroli Disease | 1 | 2007 | 12 | 0.290 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15471 | 0.290 |
Why?
|
Thromboembolism | 1 | 2014 | 1004 | 0.280 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 395 | 0.280 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2010 | 268 | 0.280 |
Why?
|
Esophagoscopy | 1 | 2009 | 398 | 0.280 |
Why?
|
Digestive System Surgical Procedures | 3 | 2018 | 584 | 0.280 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2714 | 0.280 |
Why?
|
Treatment Failure | 4 | 2019 | 2664 | 0.270 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2007 | 45 | 0.270 |
Why?
|
Liver Failure, Acute | 1 | 2008 | 182 | 0.270 |
Why?
|
Confidence Intervals | 4 | 2014 | 2932 | 0.270 |
Why?
|
Postoperative Complications | 6 | 2024 | 15889 | 0.260 |
Why?
|
Aspirin | 3 | 2013 | 3135 | 0.260 |
Why?
|
Risk Adjustment | 1 | 2010 | 603 | 0.260 |
Why?
|
Office Visits | 1 | 2010 | 596 | 0.260 |
Why?
|
Regression Analysis | 6 | 2021 | 6346 | 0.260 |
Why?
|
Ileum | 3 | 2023 | 558 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2542 | 0.260 |
Why?
|
Cost of Illness | 5 | 2023 | 1960 | 0.250 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1673 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 6 | 2024 | 6547 | 0.250 |
Why?
|
Sex Factors | 8 | 2024 | 10633 | 0.240 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2133 | 0.240 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 8055 | 0.240 |
Why?
|
Biopsy | 4 | 2021 | 6805 | 0.240 |
Why?
|
Age of Onset | 6 | 2018 | 3346 | 0.240 |
Why?
|
Polymorphism, Genetic | 2 | 2019 | 4251 | 0.240 |
Why?
|
Pyridines | 1 | 2016 | 2895 | 0.240 |
Why?
|
Adenoma | 2 | 2013 | 2163 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2017 | 3628 | 0.230 |
Why?
|
Intestines | 3 | 2019 | 1911 | 0.230 |
Why?
|
Child | 20 | 2024 | 80960 | 0.230 |
Why?
|
Disability Evaluation | 2 | 2010 | 1839 | 0.230 |
Why?
|
Research Design | 3 | 2018 | 6214 | 0.230 |
Why?
|
Databases, Factual | 8 | 2021 | 8094 | 0.220 |
Why?
|
Spinal Fractures | 1 | 2010 | 712 | 0.220 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2336 | 0.220 |
Why?
|
Physicians, Primary Care | 1 | 2010 | 625 | 0.220 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1159 | 0.220 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5522 | 0.220 |
Why?
|
Cotinine | 1 | 2024 | 206 | 0.220 |
Why?
|
Complement Factor B | 1 | 2023 | 57 | 0.220 |
Why?
|
Liver Neoplasms | 2 | 2016 | 4363 | 0.210 |
Why?
|
Pandemics | 2 | 2020 | 8749 | 0.210 |
Why?
|
Pregnancy | 10 | 2021 | 30265 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2024 | 167 | 0.210 |
Why?
|
Wisconsin | 4 | 2012 | 122 | 0.210 |
Why?
|
Pyrimidines | 4 | 2023 | 3048 | 0.210 |
Why?
|
Esters | 1 | 2023 | 212 | 0.210 |
Why?
|
Patient Care | 1 | 2008 | 629 | 0.210 |
Why?
|
Models, Statistical | 5 | 2020 | 5110 | 0.210 |
Why?
|
Nutritional Status | 2 | 2021 | 1627 | 0.200 |
Why?
|
DNA | 1 | 2016 | 7214 | 0.200 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Self Report | 4 | 2024 | 3773 | 0.200 |
Why?
|
Erythema Nodosum | 1 | 2022 | 32 | 0.200 |
Why?
|
Hip Fractures | 1 | 2010 | 997 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 2 | 2015 | 3235 | 0.200 |
Why?
|
Proctitis | 1 | 2022 | 40 | 0.200 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8559 | 0.190 |
Why?
|
Tooth Loss | 1 | 2023 | 200 | 0.190 |
Why?
|
Bile Acids and Salts | 1 | 2023 | 399 | 0.190 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1104 | 0.190 |
Why?
|
Inappropriate Prescribing | 1 | 2024 | 212 | 0.190 |
Why?
|
Amides | 1 | 2023 | 452 | 0.180 |
Why?
|
Acute Disease | 3 | 2024 | 7245 | 0.180 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3253 | 0.180 |
Why?
|
Area Under Curve | 3 | 2018 | 1645 | 0.180 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2024 | 301 | 0.180 |
Why?
|
Quality-Adjusted Life Years | 3 | 2013 | 1741 | 0.180 |
Why?
|
Infant | 7 | 2024 | 36556 | 0.180 |
Why?
|
Alberta | 1 | 2020 | 67 | 0.180 |
Why?
|
Liver Cirrhosis | 4 | 2015 | 1962 | 0.180 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3538 | 0.180 |
Why?
|
Mesalamine | 4 | 2023 | 134 | 0.170 |
Why?
|
Pneumonia | 1 | 2012 | 2164 | 0.170 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.170 |
Why?
|
Dietary Supplements | 4 | 2018 | 3443 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 455 | 0.170 |
Why?
|
Vancomycin | 2 | 2015 | 506 | 0.170 |
Why?
|
Societies, Medical | 4 | 2024 | 3968 | 0.170 |
Why?
|
Alleles | 5 | 2019 | 6901 | 0.170 |
Why?
|
Inflammation | 8 | 2023 | 10868 | 0.160 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2022 | 296 | 0.160 |
Why?
|
Hemoglobins | 2 | 2018 | 1531 | 0.160 |
Why?
|
Histological Techniques | 1 | 2019 | 194 | 0.160 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 241 | 0.160 |
Why?
|
Socioeconomic Factors | 4 | 2017 | 7861 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20776 | 0.160 |
Why?
|
Comparative Effectiveness Research | 1 | 2024 | 714 | 0.160 |
Why?
|
Estrogen Replacement Therapy | 2 | 2018 | 1209 | 0.160 |
Why?
|
Penetrance | 1 | 2021 | 386 | 0.160 |
Why?
|
Periodontitis | 1 | 2024 | 577 | 0.160 |
Why?
|
Child, Preschool | 8 | 2020 | 42683 | 0.160 |
Why?
|
Infant, Newborn | 6 | 2020 | 26428 | 0.160 |
Why?
|
Budesonide | 3 | 2023 | 162 | 0.160 |
Why?
|
Veillonella | 1 | 2018 | 21 | 0.160 |
Why?
|
ROC Curve | 2 | 2018 | 3629 | 0.160 |
Why?
|
Longitudinal Studies | 5 | 2023 | 14794 | 0.160 |
Why?
|
Blood | 1 | 2021 | 599 | 0.160 |
Why?
|
Asia | 2 | 2017 | 630 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9442 | 0.150 |
Why?
|
Prebiotics | 1 | 2018 | 41 | 0.150 |
Why?
|
Chi-Square Distribution | 3 | 2018 | 3438 | 0.150 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 150 | 0.150 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 109 | 0.150 |
Why?
|
Pyrophosphatases | 1 | 2019 | 142 | 0.150 |
Why?
|
Paper | 1 | 2018 | 83 | 0.150 |
Why?
|
Barrett Esophagus | 2 | 2013 | 495 | 0.150 |
Why?
|
Consensus | 3 | 2024 | 3214 | 0.150 |
Why?
|
Manometry | 3 | 2015 | 459 | 0.150 |
Why?
|
Vaginal Diseases | 1 | 2019 | 103 | 0.150 |
Why?
|
Colitis, Lymphocytic | 1 | 2018 | 23 | 0.150 |
Why?
|
Colitis, Collagenous | 1 | 2018 | 25 | 0.150 |
Why?
|
Uveitis | 1 | 2022 | 398 | 0.150 |
Why?
|
Research Subjects | 1 | 2020 | 249 | 0.150 |
Why?
|
Body Mass Index | 9 | 2023 | 13055 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1143 | 0.150 |
Why?
|
Sepsis | 1 | 2012 | 2610 | 0.150 |
Why?
|
Survival Rate | 4 | 2014 | 12873 | 0.150 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5375 | 0.150 |
Why?
|
Liver Function Tests | 3 | 2015 | 526 | 0.150 |
Why?
|
Massachusetts | 6 | 2018 | 8894 | 0.150 |
Why?
|
Laparoscopy | 1 | 2009 | 2055 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 554 | 0.140 |
Why?
|
Adiposity | 2 | 2018 | 1895 | 0.140 |
Why?
|
Autoimmune Diseases | 2 | 2024 | 2258 | 0.140 |
Why?
|
HIV Infections | 3 | 2016 | 17591 | 0.140 |
Why?
|
Nicotine | 1 | 2022 | 680 | 0.140 |
Why?
|
Stress, Psychological | 3 | 2018 | 4530 | 0.140 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2016 | 20 | 0.140 |
Why?
|
Lung Diseases | 1 | 2007 | 1944 | 0.140 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2018 | 193 | 0.140 |
Why?
|
Linear Models | 3 | 2018 | 5891 | 0.140 |
Why?
|
Medicare | 3 | 2021 | 6888 | 0.140 |
Why?
|
Mortality | 2 | 2019 | 2914 | 0.140 |
Why?
|
Patients | 1 | 2023 | 908 | 0.140 |
Why?
|
Genome-Wide Association Study | 7 | 2023 | 12801 | 0.130 |
Why?
|
Survival Analysis | 3 | 2016 | 10115 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 535 | 0.130 |
Why?
|
Air Pollution | 1 | 2010 | 2372 | 0.130 |
Why?
|
Iron, Dietary | 1 | 2017 | 148 | 0.130 |
Why?
|
Arthritis | 1 | 2022 | 684 | 0.130 |
Why?
|
Butyrates | 1 | 2017 | 167 | 0.130 |
Why?
|
Pets | 1 | 2016 | 47 | 0.130 |
Why?
|
Drug Substitution | 1 | 2019 | 291 | 0.130 |
Why?
|
Synthetic Biology | 1 | 2018 | 187 | 0.130 |
Why?
|
Methyltransferases | 1 | 2019 | 373 | 0.130 |
Why?
|
Health Surveys | 6 | 2018 | 4055 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 506 | 0.130 |
Why?
|
Reproductive History | 2 | 2018 | 210 | 0.130 |
Why?
|
Patient Readmission | 3 | 2021 | 3313 | 0.120 |
Why?
|
Lymphoma | 1 | 2024 | 1900 | 0.120 |
Why?
|
Heme | 1 | 2017 | 316 | 0.120 |
Why?
|
Vitamin D-Binding Protein | 1 | 2016 | 130 | 0.120 |
Why?
|
Netherlands | 1 | 2020 | 2277 | 0.120 |
Why?
|
Mass Screening | 2 | 2011 | 5457 | 0.120 |
Why?
|
Hospital Costs | 2 | 2013 | 959 | 0.120 |
Why?
|
Androgens | 1 | 2022 | 1285 | 0.120 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2018 | 365 | 0.120 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1423 | 0.120 |
Why?
|
Colon, Sigmoid | 1 | 2015 | 124 | 0.120 |
Why?
|
Dermatologic Agents | 1 | 2019 | 313 | 0.120 |
Why?
|
Disease | 1 | 2020 | 673 | 0.120 |
Why?
|
Arthralgia | 1 | 2018 | 459 | 0.120 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2014 | 56 | 0.120 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 947 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7460 | 0.110 |
Why?
|
Glutathione S-Transferase pi | 1 | 2014 | 99 | 0.110 |
Why?
|
Rectal Fistula | 1 | 2014 | 76 | 0.110 |
Why?
|
Pelvic Floor | 1 | 2015 | 138 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2024 | 1665 | 0.110 |
Why?
|
International Normalized Ratio | 1 | 2015 | 382 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 942 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2019 | 904 | 0.110 |
Why?
|
Cation Transport Proteins | 1 | 2016 | 326 | 0.110 |
Why?
|
Th1 Cells | 1 | 2019 | 1042 | 0.110 |
Why?
|
Models, Genetic | 2 | 2014 | 3449 | 0.110 |
Why?
|
Nurses | 2 | 2021 | 2501 | 0.110 |
Why?
|
Immune Tolerance | 1 | 2023 | 2323 | 0.110 |
Why?
|
Primary Health Care | 1 | 2010 | 4748 | 0.110 |
Why?
|
Hepatic Encephalopathy | 3 | 2011 | 144 | 0.110 |
Why?
|
Smad3 Protein | 1 | 2014 | 166 | 0.110 |
Why?
|
Propensity Score | 3 | 2020 | 1968 | 0.110 |
Why?
|
Postpartum Period | 1 | 2020 | 1198 | 0.110 |
Why?
|
SEER Program | 1 | 2019 | 1473 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2020 | 1070 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2024 | 2986 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 951 | 0.110 |
Why?
|
Immunity, Humoral | 1 | 2017 | 610 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2422 | 0.110 |
Why?
|
Metronidazole | 2 | 2013 | 236 | 0.100 |
Why?
|
Europe | 1 | 2020 | 3441 | 0.100 |
Why?
|
Drug Resistance | 1 | 2019 | 1599 | 0.100 |
Why?
|
Metabolome | 1 | 2020 | 1009 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2542 | 0.100 |
Why?
|
Biofeedback, Psychology | 1 | 2013 | 117 | 0.100 |
Why?
|
Health Status | 2 | 2020 | 4095 | 0.100 |
Why?
|
Gastric Juice | 1 | 2012 | 59 | 0.100 |
Why?
|
Integrins | 1 | 2017 | 843 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4045 | 0.100 |
Why?
|
Pyrroles | 1 | 2019 | 1125 | 0.100 |
Why?
|
Seafood | 1 | 2015 | 395 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4940 | 0.100 |
Why?
|
Th17 Cells | 1 | 2019 | 791 | 0.100 |
Why?
|
Siblings | 1 | 2016 | 828 | 0.100 |
Why?
|
Gastric Acid | 1 | 2012 | 98 | 0.100 |
Why?
|
Alanine Transaminase | 1 | 2015 | 606 | 0.100 |
Why?
|
Defecation | 1 | 2013 | 191 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2014 | 564 | 0.100 |
Why?
|
Genetic Markers | 1 | 2018 | 2604 | 0.100 |
Why?
|
Data Mining | 1 | 2017 | 563 | 0.100 |
Why?
|
Obesity | 4 | 2018 | 13091 | 0.100 |
Why?
|
Vomiting | 2 | 2012 | 655 | 0.100 |
Why?
|
Quality Control | 1 | 2014 | 836 | 0.100 |
Why?
|
Government Programs | 1 | 2014 | 278 | 0.100 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 364 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2023 | 1902 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2014 | 436 | 0.090 |
Why?
|
Integrin alpha4 | 1 | 2011 | 88 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 904 | 0.090 |
Why?
|
Thrombophilia | 1 | 2014 | 308 | 0.090 |
Why?
|
Hospital Charges | 2 | 2010 | 351 | 0.090 |
Why?
|
Mycobacterium | 1 | 2012 | 252 | 0.090 |
Why?
|
Parenteral Nutrition, Total | 1 | 2012 | 304 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1408 | 0.090 |
Why?
|
Carnitine | 1 | 2012 | 253 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 520 | 0.090 |
Why?
|
Histamine H2 Antagonists | 1 | 2012 | 169 | 0.090 |
Why?
|
Ubiquinone | 1 | 2012 | 183 | 0.090 |
Why?
|
Appendectomy | 1 | 2014 | 443 | 0.090 |
Why?
|
Autonomic Pathways | 1 | 2010 | 31 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3836 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1364 | 0.090 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 472 | 0.090 |
Why?
|
Herb-Drug Interactions | 1 | 2010 | 8 | 0.090 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 709 | 0.090 |
Why?
|
Laparotomy | 1 | 2013 | 459 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1602 | 0.090 |
Why?
|
Rectum | 1 | 2015 | 900 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9549 | 0.090 |
Why?
|
Panax | 1 | 2010 | 28 | 0.090 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2012 | 430 | 0.090 |
Why?
|
Tuberculin Test | 1 | 2011 | 205 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20245 | 0.090 |
Why?
|
Patient Discharge | 4 | 2022 | 3491 | 0.090 |
Why?
|
Fruit | 1 | 2015 | 1165 | 0.090 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 643 | 0.090 |
Why?
|
Vegetables | 1 | 2015 | 1199 | 0.090 |
Why?
|
Disease Management | 2 | 2019 | 2537 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3048 | 0.080 |
Why?
|
Species Specificity | 3 | 2019 | 2417 | 0.080 |
Why?
|
Patient Selection | 3 | 2021 | 4265 | 0.080 |
Why?
|
New England | 1 | 2013 | 1058 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2018 | 3139 | 0.080 |
Why?
|
Proton Pump Inhibitors | 2 | 2012 | 552 | 0.080 |
Why?
|
Colitis, Ischemic | 1 | 2009 | 32 | 0.080 |
Why?
|
Decision Trees | 1 | 2011 | 509 | 0.080 |
Why?
|
Sick Leave | 1 | 2010 | 105 | 0.080 |
Why?
|
Testosterone | 2 | 2022 | 2493 | 0.080 |
Why?
|
Hemostasis, Endoscopic | 1 | 2009 | 42 | 0.080 |
Why?
|
Pennsylvania | 1 | 2010 | 615 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10765 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2241 | 0.080 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 2008 | 40 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 843 | 0.080 |
Why?
|
Psychometrics | 1 | 2018 | 3066 | 0.080 |
Why?
|
Phylogeny | 3 | 2024 | 2843 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2016 | 1360 | 0.080 |
Why?
|
Injections, Subcutaneous | 1 | 2010 | 687 | 0.080 |
Why?
|
Data Collection | 2 | 2010 | 3324 | 0.080 |
Why?
|
Serum Albumin | 1 | 2012 | 677 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3421 | 0.080 |
Why?
|
Diverticulum | 1 | 2009 | 137 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2014 | 757 | 0.080 |
Why?
|
Quality Indicators, Health Care | 2 | 2019 | 1812 | 0.070 |
Why?
|
Medically Underserved Area | 1 | 2010 | 267 | 0.070 |
Why?
|
Antitubercular Agents | 1 | 2016 | 1397 | 0.070 |
Why?
|
Latent Tuberculosis | 1 | 2011 | 224 | 0.070 |
Why?
|
Genetic Testing | 2 | 2018 | 3591 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2014 | 1119 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 839 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3928 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5954 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2893 | 0.070 |
Why?
|
Cholagogues and Choleretics | 1 | 2007 | 39 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1134 | 0.070 |
Why?
|
Eye Diseases | 2 | 2024 | 658 | 0.070 |
Why?
|
Warfarin | 1 | 2015 | 1493 | 0.070 |
Why?
|
Ursodeoxycholic Acid | 1 | 2007 | 81 | 0.070 |
Why?
|
Drainage | 1 | 2013 | 1184 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 1048 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2592 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1305 | 0.070 |
Why?
|
Tuberculosis | 1 | 2020 | 2029 | 0.070 |
Why?
|
Illinois | 1 | 2007 | 120 | 0.070 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 100 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3269 | 0.070 |
Why?
|
Schools | 1 | 2015 | 1498 | 0.070 |
Why?
|
Eating | 1 | 2013 | 1542 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7453 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1917 | 0.070 |
Why?
|
Cholangitis | 1 | 2007 | 110 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4213 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5443 | 0.060 |
Why?
|
Anxiety | 2 | 2022 | 4672 | 0.060 |
Why?
|
Placebos | 1 | 2010 | 1667 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2016 | 3232 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 873 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2023 | 11932 | 0.060 |
Why?
|
Animals | 8 | 2023 | 169335 | 0.060 |
Why?
|
Florida | 1 | 2007 | 430 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1370 | 0.060 |
Why?
|
Emergency Treatment | 1 | 2009 | 497 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2734 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1737 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1476 | 0.060 |
Why?
|
Hypertension, Portal | 1 | 2007 | 230 | 0.060 |
Why?
|
Multiple Sclerosis | 2 | 2024 | 3250 | 0.060 |
Why?
|
Demography | 1 | 2009 | 1642 | 0.060 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 319 | 0.060 |
Why?
|
Balloon Occlusion | 1 | 2005 | 131 | 0.060 |
Why?
|
New York | 1 | 2007 | 884 | 0.060 |
Why?
|
Skin Diseases | 2 | 2024 | 1085 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1742 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5716 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3838 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1469 | 0.060 |
Why?
|
Sample Size | 2 | 2019 | 848 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2422 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7609 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2483 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2016 | 2190 | 0.060 |
Why?
|
Fatty Liver | 1 | 2010 | 810 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2763 | 0.060 |
Why?
|
Clostridium | 1 | 2023 | 100 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2713 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2023 | 99 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 2 | 2012 | 1930 | 0.050 |
Why?
|
Reoperation | 1 | 2014 | 4342 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 13021 | 0.050 |
Why?
|
Sulfasalazine | 1 | 2023 | 85 | 0.050 |
Why?
|
Educational Status | 1 | 2010 | 2515 | 0.050 |
Why?
|
Accidents, Traffic | 1 | 2008 | 819 | 0.050 |
Why?
|
Bacteria | 2 | 2024 | 2216 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.050 |
Why?
|
Enterococcus | 1 | 2023 | 159 | 0.050 |
Why?
|
Phenols | 1 | 2006 | 526 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4339 | 0.050 |
Why?
|
Lactoferrin | 1 | 2023 | 100 | 0.050 |
Why?
|
Food Handling | 1 | 2023 | 158 | 0.050 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 159 | 0.050 |
Why?
|
Lactobacillus | 1 | 2023 | 212 | 0.050 |
Why?
|
Acetaminophen | 1 | 2006 | 556 | 0.050 |
Why?
|
Hormones | 2 | 2019 | 870 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2437 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2012 | 1924 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6401 | 0.050 |
Why?
|
Income | 1 | 2010 | 1879 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2006 | 530 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1321 | 0.050 |
Why?
|
Osteoporosis | 1 | 2010 | 1606 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5928 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11262 | 0.040 |
Why?
|
Menopause | 2 | 2019 | 1656 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2022 | 386 | 0.040 |
Why?
|
Computer Simulation | 3 | 2020 | 6291 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6611 | 0.040 |
Why?
|
Medical Illustration | 1 | 2021 | 135 | 0.040 |
Why?
|
Coronary Artery Disease | 2 | 2020 | 6569 | 0.040 |
Why?
|
Haplotypes | 2 | 2019 | 2725 | 0.040 |
Why?
|
Catheterization | 1 | 2005 | 1431 | 0.040 |
Why?
|
Forecasting | 1 | 2009 | 2945 | 0.040 |
Why?
|
Computational Biology | 2 | 2024 | 3562 | 0.040 |
Why?
|
Analgesics | 1 | 2006 | 1071 | 0.040 |
Why?
|
Plasma Cells | 1 | 2023 | 599 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2553 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1620 | 0.040 |
Why?
|
Obesity, Morbid | 1 | 2010 | 1300 | 0.040 |
Why?
|
Women's Health | 2 | 2019 | 2081 | 0.040 |
Why?
|
Thrombospondins | 1 | 2019 | 196 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2024 | 716 | 0.040 |
Why?
|
Bacteroides | 1 | 2019 | 165 | 0.040 |
Why?
|
Clinical Competence | 2 | 2016 | 4860 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13698 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14752 | 0.040 |
Why?
|
Liver | 2 | 2012 | 7578 | 0.040 |
Why?
|
Ciprofloxacin | 1 | 2020 | 313 | 0.040 |
Why?
|
Enterocytes | 1 | 2019 | 219 | 0.040 |
Why?
|
Vagina | 1 | 2023 | 849 | 0.040 |
Why?
|
Prescriptions | 1 | 2020 | 388 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2010 | 3492 | 0.040 |
Why?
|
Tetanus Toxin | 1 | 2017 | 46 | 0.040 |
Why?
|
Automation | 1 | 2020 | 589 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 422 | 0.040 |
Why?
|
Bone Density | 1 | 2010 | 3574 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1150 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1197 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9499 | 0.040 |
Why?
|
Phagocytosis | 1 | 2023 | 1530 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2600 | 0.040 |
Why?
|
Haemophilus influenzae | 1 | 2017 | 177 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1376 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2024 | 1384 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4785 | 0.030 |
Why?
|
Fungi | 1 | 2019 | 345 | 0.030 |
Why?
|
Melena | 1 | 2015 | 32 | 0.030 |
Why?
|
Health | 1 | 2019 | 398 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 921 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15661 | 0.030 |
Why?
|
Mice | 3 | 2019 | 82072 | 0.030 |
Why?
|
Child Abuse | 1 | 2024 | 1091 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2008 | 2517 | 0.030 |
Why?
|
Viruses | 1 | 2019 | 373 | 0.030 |
Why?
|
Frail Elderly | 1 | 2021 | 781 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2019 | 994 | 0.030 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 181 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1952 | 0.030 |
Why?
|
Administrative Personnel | 1 | 2016 | 185 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2015 | 2784 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1609 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 294 | 0.030 |
Why?
|
Capsule Endoscopy | 1 | 2015 | 106 | 0.030 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 659 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2018 | 2085 | 0.030 |
Why?
|
Spasm | 1 | 2014 | 131 | 0.030 |
Why?
|
Patient Preference | 1 | 2021 | 947 | 0.030 |
Why?
|
Energy Intake | 1 | 2021 | 2146 | 0.030 |
Why?
|
Indiana | 1 | 2013 | 93 | 0.030 |
Why?
|
Sexual Behavior | 2 | 2018 | 2200 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2016 | 358 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 800 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 925 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 454 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4862 | 0.030 |
Why?
|
Gastric Acidity Determination | 1 | 2012 | 56 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3709 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 585 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2017 | 796 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2018 | 12806 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3345 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2012 | 122 | 0.020 |
Why?
|
British Columbia | 1 | 2012 | 240 | 0.020 |
Why?
|
Pressure | 1 | 2015 | 1172 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 570 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30266 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6086 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2017 | 1478 | 0.020 |
Why?
|
India | 1 | 2018 | 2334 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2023 | 4413 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1998 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1658 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1956 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 773 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2024 | 2895 | 0.020 |
Why?
|
Liver Failure | 1 | 2012 | 252 | 0.020 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2011 | 187 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 790 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2630 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
Dementia | 1 | 2024 | 2741 | 0.020 |
Why?
|
Sweating | 1 | 2010 | 155 | 0.020 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2010 | 118 | 0.020 |
Why?
|
Geography | 1 | 2012 | 654 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2006 | 4423 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 831 | 0.020 |
Why?
|
Proteins | 1 | 2024 | 6011 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 937 | 0.020 |
Why?
|
Epilepsy | 1 | 2024 | 3326 | 0.020 |
Why?
|
Ascites | 1 | 2011 | 338 | 0.020 |
Why?
|
Morbidity | 1 | 2014 | 1757 | 0.020 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2008 | 64 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 755 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1320 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2488 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2010 | 293 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4040 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1059 | 0.020 |
Why?
|
Carrageenan | 1 | 2006 | 71 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2623 | 0.020 |
Why?
|
Posture | 1 | 2010 | 957 | 0.020 |
Why?
|
Anemia | 1 | 2015 | 1517 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2011 | 663 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4353 | 0.020 |
Why?
|
Thailand | 1 | 2006 | 288 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2013 | 984 | 0.020 |
Why?
|
Autonomic Nervous System | 1 | 2010 | 709 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 686 | 0.020 |
Why?
|
Birth Weight | 1 | 2013 | 2121 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5334 | 0.010 |
Why?
|
Benzamides | 1 | 2010 | 1387 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 597 | 0.010 |
Why?
|
Postmenopause | 1 | 2012 | 2519 | 0.010 |
Why?
|
Infant, Premature | 1 | 2013 | 2123 | 0.010 |
Why?
|
Hepatitis C, Chronic | 1 | 2011 | 1033 | 0.010 |
Why?
|
Edema | 1 | 2006 | 766 | 0.010 |
Why?
|
Stroke | 1 | 2024 | 9756 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2701 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2121 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10276 | 0.010 |
Why?
|
Software | 1 | 2014 | 4479 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4456 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2725 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4217 | 0.010 |
Why?
|
Fever | 1 | 2006 | 1619 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 2222 | 0.010 |
Why?
|
Pain Measurement | 1 | 2006 | 3586 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8144 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8544 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3112 | 0.010 |
Why?
|
Rats | 1 | 2006 | 23786 | 0.010 |
Why?
|